Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print November 5, 2008, doi:10.1212/01.wnl.0000327823.81237.d1)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
01.wnl.0000327823.81237.d1v1
72/4/310    most recent
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nichols, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nichols, W. C.
Related Collections
Right arrow Parkinson's disease/Parkinsonism
Right arrow Genetic linkage
Right arrow Association studies in genetics
NEUROLOGY 2009;72:310-316
© 2009 American Academy of Neurology

Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset

W. C. Nichols, PhD, N. Pankratz, PhD, D. K. Marek, BS, M. W. Pauciulo, MBA, V. E. Elsaesser, BS, C. A. Halter, MS, A. Rudolph, PhD, J. Wojcieszek, MD, R. F. Pfeiffer, MD, T. Foroud, PhD For the Parkinson Study Group–PROGENI Investigators*

From Cincinnati Children’s Hospital Medical Center (W.C.N., D.K.M., M.W.P., V.E.E.), OH; University of Cincinnati School of Medicine (W.C.N.), OH; Indiana University Medical Center (N.P., C.A.H., J.W., T.F.), Indianapolis; University of Rochester (A.R.), NY; and University of Tennessee Health Science Center (R.F.P.), Memphis.

Address correspondence and reprint requests to Dr. William C. Nichols, Associate Professor of Pediatrics, Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229 bill.nichols{at}cchmc.org

Objective: To characterize sequence variation within the glucocerebrosidase (GBA) gene in a select subset of our sample of patients with familial Parkinson disease (PD) and then to test in our full sample whether these sequence variants increased the risk for PD and were associated with an earlier onset of disease.

Methods: We performed a comprehensive study of all GBA exons in one patient with PD from each of 96 PD families, selected based on the family-specific lod scores at the GBA locus. Identified GBA variants were subsequently screened in all 1325 PD cases from 566 multiplex PD families and in 359 controls.

Results: Nine different GBA variants, five previously reported, were identified in 21 of the 96 PD cases sequenced. Screening for these variants in the full sample identified 161 variant carriers (12.2%) in 99 different PD families. An unbiased estimate of the frequency of the five previously reported GBA variants in the familial PD sample was 12.6% and in the control sample was 5.3% (odds ratio 2.6; 95% confidence interval 1.5–4.4). Presence of a GBA variant was associated with an earlier age at onset (p = 0.0001). On average, those patients carrying a GBA variant had onset with PD 6.04 years earlier than those without a GBA variant.

Conclusions: This study suggests that GBA is a susceptibility gene for familial Parkinson disease (PD) and patients with GBA variants have an earlier age at onset than patients with PD without GBA variants.

Abbreviations: CI = confidence interval; GD = Gaucher disease; GDS = Geriatric Depression Scale; MMSE = Mini-Mental State Examination; NCRAD = National Cell Repository for Alzheimer’s Disease; NPL = nonparametric lod; OR = odds ratio; PD = Parkinson disease; UPDRS = Unified Parkinson’s Disease Rating Scale.


Supplemental data at www.neurology.org

e-Pub ahead of print on November 5, 2008, at www.neurology.org.

*The Parkinson Study Group–PROGENI Investigators are listed in the appendix.

Supported by R01 NS37167, MO1 RR-00750, and the National Cell Repository for Alzheimer’s Disease (U24 AG021886). This study used samples and clinical data from the National Institute of Neurological Disorders and Stroke Human Genetics Resource Center DNA and Cell Line Repository (http://ccr.coriell.org/ninds).

Disclosure: The authors report no disclosures.

Received February 26, 2008. Accepted in final form July 2, 2008.




This article has been cited by other articles:


Home page
NeurologyHome page
E. Sidransky, T. Samaddar, N. Tayebi, W. C. Nichols, N. Pankratz, and T. Foroud
MUTATIONS IN GBA ARE ASSOCIATED WITH FAMILIAL PARKINSON DISEASE SUSCEPTIBILITY AND AGE AT ONSET
Neurology, October 27, 2009; 73(17): 1424 - 1426.
[Full Text] [PDF]


Home page
NEJMHome page
E. Sidransky, M.A. Nalls, J.O. Aasly, J. Aharon-Peretz, G. Annesi, E.R. Barbosa, A. Bar-Shira, D. Berg, J. Bras, A. Brice, et al.
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
N. Engl. J. Med., October 22, 2009; 361(17): 1651 - 1661.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
W. C. Nichols, D. K. Kissell, N. Pankratz, M. W. Pauciulo, V. E. Elsaesser, K. A. Clark, C. A. Halter, A. Rudolph, J. Wojcieszek, R. F. Pfeiffer, et al.
Variation in GIGYF2 is not associated with Parkinson disease
Neurology, June 2, 2009; 72(22): 1886 - 1892.
[Abstract] [Full Text] [PDF]

Correspondence:

Read all Correspondence

Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset
Ellen Sidransky, et al.
Neurology Online, 23 Feb 2009 [Full text]
Reply from the authors
William C. Nichols, et al.
Neurology Online, 23 Feb 2009 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by AAN Enterprises, Inc.